SLA TO could then allow them to gain the IP on Equine R&D, and AGRIPRO and GI-Guard were not that far off commercialisation using BioA base, thus alt CGNC path & re-trials not necessary. If they hit before SPP then they only need to double their holding on market [& pay for options] hey presto 20% all set for HTO unless Leo does a Lebanese fandango and a back room deal is done that puts all that Opes/Ip court action to bed. Either way minor holders may be just background noise to that dance if any.
I found it a bit odd that the Oct BioNews added the cosmetic aromatic use of Eremophilone Oil as an option - at $1000/L wholesale that will need to be value added into ReGen range to make a dent in BL. Don't see why a boutique DYI "organic" termite treatment could be marketed at a premium [except Ensystex would do a bit of foot stomping]. Peter Mays old AEPMA mates wouldnt appreciate it if rather than getting a pest control bloke in at $750/$1k p/a a eco friendly 5L DYI spray pack could be sold off the shelf at Bunnings for 1/3 that [which may be commercially viable] Im sure ACA will help out with a bit of Aussie product promotion.
BPO Price at posting:
0.8¢ Sentiment: Hold Disclosure: Held